secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2025-03-28T23:59:59+00:00
Accession:  0001104659-25-029405
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Werner Cautreels retiring; Iain Dukes appointed Interim CEO effective March 31, 2025
--------------------------------------------------------------------------------

- Werner Cautreels to retire as CEO effective upon filing 2024 10-K around March 31; remains on board and as special advisor.
- Iain Dukes, Executive Chairman, appointed Interim CEO; continues as Chairman.
- Cautreels receives $10,000 lump sum and $10,000/month consulting fee for one year as special advisor.
- No compensation changes for Dukes yet; amendment to his offer letter expected soon.
- Investor update call scheduled for March 31, 2025 at 10:00 AM ET to review pipeline progress.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925029405/0001104659-25-029405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925029405/tm2510819d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-029405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer